SCOPUS 정보 검색 플랫폼

Annals of Emergency Medicine

Volumn 27, Issue 3, 1996, Pages 382-385

Atypical presentation of 4-aminopyridine overdose

(2) Pickett, T A a Enns, R a

a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; POTASSIUM CHANNEL;

ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; CASE REPORT; CLINICAL FEATURE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; NERVE CONDUCTION; PRIORITY JOURNAL; SELF MEDICATION; TONIC CLONIC SEIZURE;

EID: 0029928052 PISSN: 01960644 EISSN: None Source Type: Journal
DOI: 10.1016/S0196-0644(96)70277-9 Document Type: Article

Times cited : (34)

References (15)

1
- 0025253455
- Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis
- FA Davis D Stefoski J Rush Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis Ann Neurol 27 1990 186 192
- (1990) Ann Neurol , vol.27 , pp. 186-192
- Davis, FA¹ Stefoski, D² Rush, J³

2
- 0026719595
- The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo-controlled, double-blind, cross-over study
- HAM Van Diemen CH Polman TMMM van Dongen The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo-controlled, double-blind, cross-over study Ann Neurol 32 1992 123 130
- (1992) Ann Neurol , vol.32 , pp. 123-130
- Van Diemen, HAM¹ Polman, CH² van Dongen, TMMM³

3
- 0023134727
- 4-Aminopyridine improves clinical signs in multiple sclerosis
- D Stefoski FA Davis M Faut 4-Aminopyridine improves clinical signs in multiple sclerosis Ann Neurol 21 1987 71 77
- (1987) Ann Neurol , vol.21 , pp. 71-77
- Stefoski, D¹ Davis, FA² Faut, M³

4
- 0018621819
- Human botulism caused by Clostridium botulinum type E: The Birmingham outbreak
- AP Ball ID Hopkinson JGP Farrell Human botulism caused by Clostridium botulinum type E: The Birmingham outbreak Q J Med 48 1979 473 491
- (1979) Q J Med , vol.48 , pp. 473-491
- Ball, AP¹ Hopkinson, ID² Farrell, JGP³

5
- 0019476136
- Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission
- NMF Murray J Newsom-Davis Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission Neurology 31 1981 265 271
- (1981) Neurology , vol.31 , pp. 265-271
- Murray, NMF¹ Newsom-Davis, J²

6
- 0020321345
- The aminopyridines
- WE Glover The aminopyridines Gen Pharmacol 13 1982 259 285
- (1982) Gen Pharmacol , vol.13 , pp. 259-285
- Glover, WE¹

7
- 0028346225
- A reversed-phase ion-pair liquid chromatography method for the determination of 4-aminopyridine in Sprague-Dawley rats
- MJ Fossler J Leslie M Burke A reversed-phase ion-pair liquid chromatography method for the determination of 4-aminopyridine in Sprague-Dawley rats J Pharm Biomed Anal 12 1994 281 285
- (1994) J Pharm Biomed Anal , vol.12 , pp. 281-285
- Fossler, MJ¹ Leslie, J² Burke, M³

8
- 0018853878
- Poisoning with 4-aminopyridine: Report of three cases
- DA Spyker C Lynch J Shabanowitz Poisoning with 4-aminopyridine: Report of three cases Clin Toxicol 16 1980 487 497
- (1980) Clin Toxicol , vol.16 , pp. 487-497
- Spyker, DA¹ Lynch, C² Shabanowitz, J³

9
- 0028148351
- Characterization of 4-aminopyridine in overdose
- CM Stork RS Hoffman Characterization of 4-aminopyridine in overdose Clin Toxicol 32 1994 583 587
- (1994) Clin Toxicol , vol.32 , pp. 583-587
- Stork, CM¹ Hoffman, RS²

10
- 0024226640
- Effects of 4-aminopyridine in experimental CNS demyelination
- R Kaji AJ Sumner Effects of 4-aminopyridine in experimental CNS demyelination Neurology 38 1988 1884 1887
- (1988) Neurology , vol.38 , pp. 1884-1887
- Kaji, R¹ Sumner, AJ²

11
- 0025989270
- 4-Aminopyridine in multiple sclerosis: Prolonged administration
- D Stefoski FA Davis WE Fitzsimmons 4-Aminopyridine in multiple sclerosis: Prolonged administration Neurology 41 1991 1344 1348
- (1991) Neurology , vol.41 , pp. 1344-1348
- Stefoski, D¹ Davis, FA² Fitzsimmons, WE³

12
- 0027314926
- 4-Aminopyridine in patients with multiple sclerosis: Dosage and serum level related to efficacy and safety
- HAM Van Diemen CH Polman JC Koetsier 4-Aminopyridine in patients with multiple sclerosis: Dosage and serum level related to efficacy and safety Clin Neuropharmacol 16 1993 195 204
- (1993) Clin Neuropharmacol , vol.16 , pp. 195-204
- Van Diemen, HAM¹ Polman, CH² Koetsier, JC³

13
- 0028245456
- The effects of 4-aminopyridine in multiple sclerosis patients: Results of a randomized, placebo-controlled, double-blind, concentration-controlled crossover trial
- CT Bever D Young PA Anderson The effects of 4-aminopyridine in multiple sclerosis patients: Results of a randomized, placebo-controlled, double-blind, concentration-controlled crossover trial Neurology 44 1994 1054 1059
- (1994) Neurology , vol.44 , pp. 1054-1059
- Bever, CT¹ Young, D² Anderson, PA³

14
- 0027231589
- Basal ganglia involvement in multiple sclerosis with alternating side paroxysmal dystonia
- A Lugaresi A Uncini D Gambi Basal ganglia involvement in multiple sclerosis with alternating side paroxysmal dystonia J Neurol 240 1993 257 261
- (1993) J Neurol , vol.240 , pp. 257-261
- Lugaresi, A¹ Uncini, A² Gambi, D³

15
- 0001526268
- Effect of lowering of body temperature on the symptoms and signs of multiple sclerosis
- CW Watson Effect of lowering of body temperature on the symptoms and signs of multiple sclerosis N Engl J Med 261 1959 1253 1259
- (1959) N Engl J Med , vol.261 , pp. 1253-1259
- Watson, CW¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.